Patients With Obstructive Jaundice In Sohag University Hospital

NCT06456476 | Recruiting

• 1 other identifier: Soh-Med-24-04-03MS
• Study Type: observational
• Target: 130
• Locations: 1 country
• Sites: 1

Brief Summary

Study of patients with obstructive jaundice in Sohag university hospital study the clinical, laboratory and imaging charachteristics in patients with obstructive jaundice admitted to sohag university hospital, and to study the available therapeutic options which meight improve patient's quality of life and increase survival rates.

Conditions

Obstructive Jaundice

Outcome Measures

Primary Outcomes (1)

• Study Of Patients With Obstructive Jaundice In Sohag University Hospital

  rate of patients with obstructive jaundice admitted in sohag university hospital

  6 months

Study Arms (1)

patints with obstructive jaundicep

The patients, clinically diagnosed as suffering from obstructive jaundice and referred to the Department of Internal Medicine for further evaluation.

Diagnostic Test: ERCP

Interventions

ERCP DIAGNOSTIC_TEST

ERCP used only if needed in some patients

patints with obstructive jaundicep

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The patients, clinically diagnosed as suffering from obstructive jaundice and referred to the Department of Internal Medicine for further evaluation.

You may qualify if:

• The patients, clinically diagnosed as suffering from obstructive jaundice and referred to the Department of Internal Medicine for further evaluation.

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

RECRUITING

Related Publications (4)

• deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart HX, Fontana RJ, Kleiner DE, Bonkovsky HL; Drug-Induced Liver Injury Network (DILIN). Amoxicillin-Clavulanate-Induced Liver Injury. Dig Dis Sci. 2016 Aug;61(8):2406-2416. doi: 10.1007/s10620-016-4121-6. Epub 2016 Mar 22.

  PMID: 27003146 BACKGROUND

• Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004 Jan 15;69(2):299-304.

  PMID: 14765767 BACKGROUND

• Moghimi M, Marashi SA, Salehian MT, Sheikhvatan M. Obstructive jaundice in Iran: factors affecting early outcome. Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):515-9.

  PMID: 18842499 BACKGROUND

• Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol. 2003 Mar;9(3):385-91. doi: 10.3748/wjg.v9.i3.385.

  PMID: 12632482 BACKGROUND

MeSH Terms

Conditions

Jaundice, Obstructive

Interventions

Cholangiopancreatography, Endoscopic Retrograde

Condition Hierarchy (Ancestors)

Jaundice; Hyperbilirubinemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Skin Manifestations; Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cholangiography; Radiography, Abdominal; Radiography; Diagnostic Imaging; Diagnostic Techniques and Procedures; Diagnosis; Diagnostic Techniques, Digestive System; Endoscopy, Digestive System; Endoscopy; Diagnostic Techniques, Surgical; Digestive System Surgical Procedures; Surgical Procedures, Operative; Minimally Invasive Surgical Procedures

Central Study Contacts

Alshaimaa I Hamdy, resident

CONTACT

01068032698; alshaimaa_ibrahim_post@med.sohag.edu.eg

Usama A Arafa, professor

CONTACT

0106364007

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Target Duration: 6 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principal investigator

Study Record Dates

• First Submitted: May 27, 2024
• First Posted: June 13, 2024
• Study Start: May 20, 2024
• Primary Completion: November 20, 2024
• Study Completion: November 20, 2024
• Last Updated: June 13, 2024

Record last verified: 2024-05

Locations

EG (1)